Changes of Estimated Glomerular Filtration Rate and Glycated Hemoglobin A1c in Diabetic Macular Edema Patients Treated by Ranibizumab and Aflibercept in the Tertiary Referral Hospital

<i>Background and Objectives</i>: Intravitreal injections (IVI) of vascular endothelial growth factor (VEGF) inhibitors are guideline-indicated treatments for diabetic macular edema (DME). However, some recent data have suggested that IVI VEGF inhibitors might, through systemic absorptio...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Medicina
المؤلفون الرئيسيون: Wei-Ning Ku, Peng-Tai Tien, Chun-Ju Lin, Chun-Chi Chiang, Ning-Yi Hsia, Chun-Ting Lai, Chih-Hsin Muo, Henry Bair, Huan-Sheng Chen, Jane-Ming Lin, Wen-Lu Chen, Yi-Yu Tsai
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2022-08-01
الموضوعات:
HbA1c
DME
anti-VEGF
IVI
eGFR
intravitreal injections
الوصول للمادة أونلاين:https://www.mdpi.com/1648-9144/58/8/1081

الانترنت

https://www.mdpi.com/1648-9144/58/8/1081

مواد مشابهة